American pharmaceutical giant Pfizer has stopped selling one of its lucrative vaccines for children in China, the company said. Pfizer gave no explanation for stopping its sales of the Prevnar vaccine. This vaccine helps prevent infections such as pneumonia, which killed an estimated 935,000 children under the age of five globally in 2013, according to the World Health Organization (WHO).
"Based on a careful assessment of this situation, we have decided to cease our vaccines commercial operations in China at this time, effective immediately," a spokeswoman said in an email Thursday, adding that the drug's import license had expired. Pfizer anticipates a shortage of Prevnar in China before the sale of a new vaccine can begin.
US Pharma Giant Pfizer Takes Over $17 Billion Hospira
US pharmaceutical giant Pfizer will expand its line of drugs and therapies with the takeover of $17 billion Hospira.
Advertisement
Prevnar vaccines generated $4.5 billion in revenue last year for Pfizer. They are the second largest contributor to the company's revenues, according to Pfizer's annual report.
The spokeswoman said that the other activities of the company, which employs about 9,000 people in China, were not affected. China is one of Pfizer's largest markets after the US and Canada. About 200 positions at the company will be affected by the end of the vaccine sale. The setback comes as pharmaceutical companies have struggled to gain Chinese authorities' approval for many of their drugs.
Pfizer said it is in talks with Chinese regulators to register and provide an improved vaccine "as soon as possible".
Source: AFP
Pfizer said it is in talks with Chinese regulators to register and provide an improved vaccine "as soon as possible".
Source: AFP
FDA Priority Review for Pfizer Breast Cancer Drug
An experimental breast cancer treatment will be given an accelerated review by US regulators, Pfizer has revealed.
Advertisement
 Cameron Warns Against Protectionism, but Asks for Pfizer Assurance on AstraZeneca TakeoverDavid Cameron backed foreign investment, saying that it would be beneficial for Britain. | Advertisement
|
Takeover Bid of AstraZeneca Given Up by Drugmaker Pfizer
Takeover bid of British AstraZeneca was given up by the US drugmaker Pfizer after its final $117-billion offer was rejected last week, the latter said on Monday.
Advertisement
Recommended Readings
Latest Child Health News
Children with amblyopia or lazy eye who underwent digital vision training, showed no appreciable improvement in their eyesight.
In 2022, over 20% of children worldwide lacked adequate calories for growth, with 45+ million showing wasting (underweight for height).
After PCV7 licensure, pneumococcal infection rates in children aged 5+ with sickle cell disease significantly decreased.
Breast milk concentration of certain key proteins indicates abundance of healthy bacteria in babies' guts.
Compared to young children who grow up in rural areas, city kids are more prone to suffer respiratory infections due to environmental factors.
